Table 4.
Ag in tissues (liver, spleen and kidney) at 48 h after oral gavage with 10 mg/kg bw/d AgNP or AgOAc.a
| Dosing group | Vehicle (coating) | Ag dose (mg/kg) | Ag in liver (ng/g)b
|
Ag in liver (% recovery administered dose)
|
Ag in spleen (ng/g)b
|
Ag in spleen (% recovery administered dose)
|
Ag in kidney (ng/g)b
|
Ag in kidney (% recovery administered dose)
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Meana | SD | |||
| AgNP 20 nm | 2 mM citrate | 10 | 16.87 | 11.43 | 0.008 | 0.005 | 22.94 | 9.78 | 0.0110 | 0.0050 | 2.62 | 0.81 | 0.0010 | 0.0003 |
| AgNP 110 nm | 2 mM citrate | 10 | 11.19 | 7.45 | 0.005 | 0.003 | 24.45 | 11.13 | 0.0114 | 0.0053 | 2.12 | 0.20 | 0.0010 | 0.0001 |
| AgNP 20 nm | 10 kDa PVP | 10 | 12.88 | 4.83 | 0.006 | 0.002 | 26.44 | 9.34 | 0.0128 | 0.0045 | 2.21 | 0.14 | 0.0011 | 0.0001 |
| AgNP 110 nm | 40 kDa PVP | 10 | 8.11 | 6.65 | 0.004 | 0.003 | 33.17 | 18.11 | 0.0164 | 0.0091 | 2.43 | 0.20 | 0.0012 | 0.0001 |
| AgOAc | sterile H2O | 10 | 301.32‡‡‡ | 162.50 | 0.144‡‡‡ | 0.810 | 94.44‡‡ | 60.37 | 0.045‡ | 0.029 | 12.54‡‡‡ | 6.77 | 0.0060‡‡‡ | 0.0034 |
| na | 2 mM citrate | 0 | 1.04 | 0.03 | na | na | 15.34 | 0.45 | na | na | 2.23 | 0.23 | na | na |
| na | 10 kDa PVP | 0 | 0.98 | 0.07 | na | na | 22.78 | 9.92 | na | na | 2.28 | 0.40 | na | na |
| na | 40 kDa PVP | 0 | 1.00 | 0.06 | na | na | 12.33 | 6.87 | na | na | 2.22 | 0.30 | na | na |
| na | sterile H2O | 0 | 0.92 | 0.09 | na | na | 22.94 | 11.46 | na | na | 2.17 | 0.17 | na | na |
Significantly different from AgNP groups
p<0.0001,
p = 0.002,
p = 0.003; one-way ANOVA, Tukey’s multiple comparisons test.
Note that mass recovery of Ag is expressed in ng/g tissue.